| Ytd | -25.91% | |
| 1y | 110.29% |
| Open | 1.35 | Prev Close | 1.40 | Low | 1.34 | High | 1.44 | Mkt Cap | 22.58M |
| Vol | 521.24K | Avg Vol | 837.16K | EPS | -0.58 | P/E | -2.47 | Forward P/E | -1.44 |
| Beta | 1.30 | Short Ratio | 1.92 | Inst. Own | 31.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-22 | 50-d Avg | 1.55 | 200-d Avg | 1.84 | 1yr Est | 3.60 |
IBIO News
SAN DIEGO, Aug. 04, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), a clinical-stage biotechnolo
Gainers Gossamer Bio (NASDAQ:GOSS) shares rose 28.8% to $0.26 during Monday's after-market sess
Single-dose IBIO-610 achieved up to 98% inhibition of active Activin E through eight weeks, supporti
SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO) (“iBio” or the “Company”), an
IBIO-600 is potentially best-in-class, long-acting anti-myostatin monoclonal antibody designed to pr
Received regulatory clearance to initiate its Phase 1 clinical trial of IBIO-600 in Australia Announ
IBIO-600 is a potentially best-in-class, long-acting anti-myostatin monoclonal antibody designed to
iBio, Inc. (IBIO) Discusses Bispecific Antibody Program and Rationale for Targeting Pulmonary Hypert
Company to host corporate update call on Tuesday, March 17, at 4 p.m. ET Company to host corporate u
Study demonstrated reduction of 6.7% visceral fat and 5.2% total fat mass in obese non-human primate
iBio (NASDAQ: IBIO - Get Free Report) and Gemini Therapeutics (NASDAQ: GMTX - Get Free Report) are b
SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), an AI-driven innovator of pr
Vaxxinity (NASDAQ: VAXX - Get Free Report) and iBio (NYSE: IBIO - Get Free Report) are both small-ca
Secured $26 Million in PIPE Financing Led by a Top-Tier Biotech Investor to Advance Preclinical Prog
iBio (IBIO) possesses the right combination of the two key ingredients for a likely earnings beat in
Vincerx Pharma (NASDAQ: VINC - Get Free Report) and iBio (NYSE: IBIO - Get Free Report) are both sma
Shares of iBio, Inc. (NYSEMKT:IBIO - Get Free Report) traded up 8.3% during trading on Friday. The s
SAN DIEGO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of pre
iBio (NYSE: IBIO - Get Free Report) and PyroGenesis Canada (NASDAQ: PYRGF - Get Free Report) are bot
SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), an AI-driven innovator of pr
iBio, Inc. (IBIO) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estim
On Tuesday, 838 companies hit new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
Stocks That Hit 52-Week Highs On Friday